Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer

NCT01594398 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer
Non Small Cell Lung Cancer (NSCLC)
Breast Cancer
Estrogen Receptor Breast Cancer

Interventions

DRUG: entinostat
DRUG: entinostat
DRUG: Erlotinib
DRUG: Erlotinib
DRUG: Exemestane
DRUG: Exemestane

Sponsor

Syndax Pharmaceuticals